- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03376308
Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response (VDIAMETER)
During general anesthesia, intravenous (IV) medications can disrupt the patient's comfort by causing a pain sensation or a withdrawal response in the heart. Propofol and rocuronium are among the most common causes of this condition.
In recent years, the use of ultrasonography (USG) in anesthesia has become widespread with the rapid advancement of technology. The use of the patient's head is a non invasive method.
This study is aimed to evaluate whether the size of the venous diameter assessed by ultrasonography in our study is an effect on pain and withdrawal response after drug injections.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
The study was conducted in patients who underwent surgical procedures under general anesthesia by obtaining consent from the Adnan Menderes University Medical Faculty Ethics Board and written consent from the patients and then being admitted to the ASA I-II age group 18-70 years of age.
Patients with peripheric vascular disease, vasculitis, rheumatologic disease, non-cooperative, under the age of 18 and over 70, ASA III and above, allergic to general anesthetic agents and refusing to participate in the study were excluded from the study.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Aydın, Kalkoen, 09100
- Adnan Menderes University Training and Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
18- 70 years of ASA (American society of anesthesiology) physical status I- II who were to undergo various elective operations
Exclusion Criteria:
Rheumatologic disease Peripheric vascular disease Vasculitis Patients with chronic pain syndrome, Patients with neurologic deficits, Patients with thrombophlebitis, Patients with difficult venous access, Patients with allergy
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Geval-overgang
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
Group 1
Venous diameter measurements were made via the USG in the hand dorsum. Transverse venous diameter ≤2mm was defined group 1. Anesthesia induction drugs were all treated in the same order and dose. Pain score, withdrawal movement score and hemodynamic response was recorded. |
Four poin scala 0=No Pain
Withdrawal movements
Hemodynamic data were recorded in the patients taken in the operation room.
(T0).
Hemodynamic values (T1) measured 1 minute after administration of intravenous propofol were recorded.
Hemodynamic values (T2) measured 1 minute after administration of intravenous rocuronium were recorded.
Hemodynamic values (T3) measured 1 minute after administration of endotracheal intubation were recorded.
|
Group 2
Venous diameter measurements were made via the USG in the hand dorsum.Transverse venous diameter >2mm was defined group 2.Anesthesia induction drugs were all treated in the same order and dose. Pain score, withdrawal movement score and hemodynamic response was recorded. |
Four poin scala 0=No Pain
Withdrawal movements
Hemodynamic data were recorded in the patients taken in the operation room.
(T0).
Hemodynamic values (T1) measured 1 minute after administration of intravenous propofol were recorded.
Hemodynamic values (T2) measured 1 minute after administration of intravenous rocuronium were recorded.
Hemodynamic values (T3) measured 1 minute after administration of endotracheal intubation were recorded.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
The injection pain due to propofol
Tijdsspanne: 6 month
|
Pain will be recorded and graded using a 4-point scale (none, mild, moderate, or severe).
|
6 month
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
The withdrawal movement due to rocuronium
Tijdsspanne: 6 month
|
Withdrawal movements are scored as follows: (a) no movement response, (b) movement limited to the wrist, (c)movement limited to the elbow/shoulder, or (d) generalized movement response.
|
6 month
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- VASCULAR DIAMETER
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Pain Score
-
NYU Langone HealthVoltooidBloedarmoede bij prematuren (AOP)Verenigde Staten
-
Cameroon Baptist Convention HealthCarolinas Medical CenterVoltooid
-
Stuart WongActief, niet wervendOrale mucositisVerenigde Staten
-
Teesside UniversityConnect Health LtdVoltooid
-
Pfizer's Upjohn has merged with Mylan to form Viatris...VoltooidNeuralgie | Neuropatische pijn | Zenuwpijn
-
University of FloridaAgency for Healthcare Research and Quality (AHRQ)Nog niet aan het wervenMusculoskeletale pijn | Chronische pijn | Opioïde gebruik
-
University of AlbertaAlberta Health services; Ontario Bioscience Innovation OrganizationVoltooid
-
VA Office of Research and DevelopmentVoltooid
-
Washington University School of MedicineNational Institutes of Health (NIH)Werving
-
Rigshospitalet, DenmarkFrederiksberg University Hospital; Defactum, Central Denmark RegionActief, niet wervend